cephalosporin c has been researched along with cefetamet in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (60.00) | 18.7374 |
1990's | 13 (37.14) | 18.2507 |
2000's | 1 (2.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M | 1 |
Cullmann, W; Knöller, J; König, W; Scheffer, J | 1 |
Edwards, DJ; Stoeckel, K | 1 |
Black, WA; Bowie, WR; Chan, DG; Shaw, CE | 1 |
Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA | 1 |
Jalanko, E; Renkonen, OV; Scheinin, L; Valle, T | 1 |
Easmon, CS; Ison, CA; Woodford, N | 1 |
Hohl, P; Kafader, FM; Salfinger, M | 1 |
Hardegger, U; Wüst, J | 1 |
Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M | 1 |
Brandt, R; Dubach, UC; Koup, JR; Stoeckel, K; Wyss, R | 1 |
Aldridge, KE; Sanders, CV; Schiro, DD | 1 |
Braveny, I; Machka, K | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Mittermayer, H | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Arnold, K; Chau, PY; Leung, YK; Ng, WW | 1 |
Barry, AL; Jones, RN | 1 |
Houben, AW; Stobberingh, E; van Boven, CP | 1 |
Lang, SD; Thomas, MG | 1 |
Andrews, JM; Piddock, LJ; Wise, R | 1 |
Fass, RJ; Helsel, VL | 1 |
Peeters, M; Piot, P | 1 |
Chau, PY; Leung, YK; Ng, WS; Wong, PC | 1 |
Bauernfeind, A; Cornaglia, G; Fontana, R; Ligozzi, M; Satta, G | 1 |
Biedenbach, DJ; Jones, RN | 1 |
Bale, MJ; Jones, RN | 1 |
Blandino, G; Nicoletti, G; Speciale, A | 1 |
Kotis, E; Nikolaidis, P; Sofianou, D; Tourkantonis, A; Tsakris, A | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
Verbist, L; Verhaegen, J | 1 |
Endo, H; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nishinari, C; Suzuki, Y | 1 |
Aleksić, M; Burić, N; Kapetanović, V; Popović, G; Savić, V | 1 |
1 review(s) available for cephalosporin c and cefetamet
Article | Year |
---|---|
The pharmacokinetics of new oral cephalosporins in children.
Topics: Administration, Oral; Adult; Biological Availability; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Half-Life; Humans; Infant; Metabolic Clearance Rate | 1992 |
34 other study(ies) available for cephalosporin c and cefetamet
Article | Year |
---|---|
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones | 1992 |
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1992 |
Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.
Topics: Cefaclor; Ceftizoxime; Cell Adhesion; Cephalosporins; Chemotaxis, Leukocyte; Granulocytes; Humans; In Vitro Techniques; Inflammation; Leukotrienes; Luminescent Measurements; Neutrophils; Phagocytosis | 1992 |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Chlamydia trachomatis; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1987 |
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 1987 |
In vitro activity of RO 15-8074 and RO 19-5247.
Topics: Amoxicillin; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus; Streptococcus | 1987 |
The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Neisseria gonorrhoeae; Penicillin Resistance | 1987 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Humans | 1987 |
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids | 1988 |
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
Topics: Administration, Oral; Adult; Biological Availability; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Fasting; Humans; Infusions, Intravenous; Male; Protein Binding; Random Allocation | 1988 |
Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
Topics: Cefmenoxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1987 |
Comparative in vitro activity of cefetamet (RO 15-8074).
Topics: Ampicillin; Cefaclor; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Enterobacteriaceae | 1987 |
In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Ceftizoxime; Cephalosporins; Enzyme Stability; Microbial Sensitivity Tests | 1986 |
In vitro activity of cefetamet (Ro 15-8074).
Topics: Anti-Bacterial Agents; Bacteria; Cefazolin; Ceftizoxime; Cephalosporins; Doxycycline; Drug Combinations; Enterobacteriaceae; Haemophilus influenzae; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Ceftizoxime; Cefuroxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas; Staphylococcus | 1986 |
Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1987 |
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Computers; Microbial Sensitivity Tests; Predictive Value of Tests; Regression Analysis | 1987 |
In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247.
Topics: Aztreonam; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Enterobacteriaceae; Pseudomonas | 1987 |
Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1986 |
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
Topics: Bacteria; Blood Proteins; Cefmenoxime; Ceftizoxime; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Protein Binding | 1986 |
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1986 |
In-vitro activity of Ro-15-8074, a new oral cephalosporin.
Topics: Ampicillin; Bacteria; Cefaclor; Cefadroxil; Ceftizoxime; Cephalosporins; Drug Combinations; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefaclor; Ceftizoxime; Cephalosporins; Clavulanic Acids; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1985 |
PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
Topics: Bacterial Proteins; Biological Transport; Carrier Proteins; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1994 |
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
Topics: Administration, Oral; Cefdinir; Cefprozil; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Evaluation Studies as Topic; False Positive Reactions; Humans; Microbial Sensitivity Tests; Proteus vulgaris; Providencia | 1994 |
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Topics: Anti-Infective Agents; Cefdinir; Cefepime; Cefmetazole; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones | 1993 |
Third generation oral cephalosporins: comparative in vitro kinetics.
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalosporins; Escherichia coli; Haemophilus influenzae; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
The activity of cefetamet against enterobacterial isolates from community-acquired urinary tract infections.
Topics: Ceftizoxime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Greece; Humans; Lactams; Urinary Tract Infections | 1996 |
[Antimicrobial activities of cefetamet against clinical isolates from urinary tract infection].
Topics: Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs; Urinary Tract Infections | 1996 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
[Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
Topics: Anti-Bacterial Agents; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1999 |
Acidity constants of cefetamet, cefotaxime and ceftriaxone; the effect of the substituent at C3 position.
Topics: Carbon; Carboxylic Acids; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chemistry, Pharmaceutical; Chemistry, Physical; Hydrogen-Ion Concentration; Ions; Kinetics; Models, Chemical; Models, Statistical; Molecular Conformation; Molecular Structure; Potentiometry; Protons; Stereoisomerism; Thiazoles; Triazines | 2005 |